#019 Augmentin, India's Top Selling Drug episode artwork

EPISODE · Jun 14, 2023 · 27 MIN

#019 Augmentin, India's Top Selling Drug

from The Core Report · host The Core

On today’s episode, financial journalist Govindraj Ethiraj talks to Sheetal Sapale, vice president at integrated healthcare technology platform Pharmarack as well as Tushar Sachade, Partner at PricewaterhouseCoopers & Company.SHOW NOTES[00:50] Did you know which is India’s top selling drug and more importantly for what? Get ready for a few surprises with Sheetal Sapale[09:16] Tyre maker MRF stock touches 100,000 on the bourses and some history on MRF[15:01] Rich Indians are still fleeing abroad but lesser this year[18:08] Can India’s angel tax be reinvented? with Tushar Sachade For more of our coverage check out thecore.inSubscribe to our NewsletterFollow us on:Twitter | Instagram | Facebook | Linkedin | Youtube

Episode metadata supplied by the publisher feed · Published Jun 14, 2023

Embed this episode

NOW PLAYING

#019 Augmentin, India's Top Selling Drug

0:00 27:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Core Report?

This episode is 27 minutes long.

When was this The Core Report episode published?

This episode was published on June 14, 2023.

Can I download this The Core Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!